Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
24.34
-0.42 (-1.70%)
At close: Dec 5, 2025, 4:00 PM EST
23.83
-0.51 (-2.10%)
After-hours: Dec 5, 2025, 7:58 PM EST
Kodiak Sciences Employees
Kodiak Sciences had 109 employees as of December 31, 2024. The number of employees decreased by 2 or -1.80% compared to the previous year.
Employees
109
Change (1Y)
-2
Growth (1Y)
-1.80%
Revenue / Employee
n/a
Profits / Employee
-$1,993,908
Market Cap
1.29B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KOD News
- 22 days ago - Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results - PRNewsWire
- 23 days ago - Kodiak Sciences to Present at Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI) - PRNewsWire
- 2 months ago - New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI) - PRNewsWire
- 3 months ago - Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI) - PRNewsWire
- 3 months ago - Harbour BioMed Reports 2025 Interim Results - PRNewsWire
- 3 months ago - Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock - Benzinga
- 3 months ago - Kodiak Sciences to Present at American Chemical Society Fall 2025 - PRNewsWire